RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $61,000 | -66.5% | 35,886 | -59.3% | 0.00% | -100.0% |
| Q3 2021 | $182,000 | -10.8% | 88,163 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $204,000 | -22.7% | 88,163 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $264,000 | -1.9% | 94,450 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $269,000 | -80.4% | 94,450 | -85.5% | 0.00% | -87.5% |
| Q3 2020 | $1,369,000 | -30.7% | 652,036 | +50.2% | 0.01% | -38.5% |
| Q2 2020 | $1,975,000 | +11.0% | 434,061 | +148.0% | 0.01% | 0.0% |
| Q2 2019 | $1,780,000 | – | 175,055 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |